Trio Of Pharma Cos. Fight Post-Trial Bids In $1B Patent Row

Trio Of Pharma Cos. Fight Post-Trial Bids In $1B Patent Row

Three pharmaceutical companies involved in a $1 billion patent infringement suit over a quality control test for a generic blood thinner contested each other’s dueling bids for post-trial relief Wednesday — including judgment or a new trial ...read more

  • Tags: